Small cap News

JACK’s Stocktwits sentiment dropped to ‘extremely bearish’ amid extremely high message volume, signaling rising caution heading into quarterly results next week.

Investor focus shifted to Wednesday’s U.S. jobs report, wage data, Fed remarks, and the federal budget release.

The company said that EVO301 achieved highly statistically significant outcomes in adult patients with moderate-to-severe atopic dermatitis.

Nektar announced positive results from the 36-week blinded maintenance period of the 52-week REZOLVE-AD study of its experimental drug, rezpegaldesleukin.

The company plans to fix software issues through free over-the-air updates, bringing affected vehicles to Aspen 3.5.6, Alder 2.1.0, or newer versions.

SAT-3247, an oral therapy aimed at restoring muscle repair, is now in Phase 2 testing in children with DMD.

The dip in the Michael Saylor-backed company comes even after it picked up more Bitcoin for around $90 million on Monday.

The company stated that its product, Symvess, is the only human-derived bioengineered blood vessel approved by the U.S. Food and Drug Administration.

Momentus will deliver a NASA CubeSat to low Earth orbit to demonstrate joint rendezvous and proximity operations as well as formation flying.

Monday’s catalysts include remarks from Atlanta Fed President Raphael Bostic, Fed Governor Christopher Waller, and Fed Governor Stephen Miran.

According to BofA’s latest Flow Show report, as cited by MarketWatch, the firm’s proprietary Bull & Bear Indicator is currently at a nearly two-decade high of 9.6, the highest since March 2006.

After a choppy start to February, selling pressure intensified late Thursday. From the NYSE floor, veteran trader Peter Tuchman says the tone has clearly shifted.

Key catalysts for Friday include preliminary consumer sentiment data, remarks from Fed Vice Chair Philip Jefferson, and the consumer credit report.

The S&P 500 fell by 37 points to hover at 6,845, while the Dow Jones Industrial Average was down by 0.56%, and the Nasdaq Composite declined 0.51%.

Faraday Future unveiled three humanoid and quadruped AI robots at NADA, signaling a Tesla-style pivot beyond EVs.

Other than both companies being in the cryptocurrency space, the shares of Circle and Bullish were trading below their IPO levels.

An analyst noted that February has historically been a difficult month for equities.

Sunrun’s stock has gained nearly 13% so far this year, building on the 98% jump in 2025 as the company’s solar products see steady demand.

According to the agreement, Summit Products Group will distribute Hydrelix, NovaForm, and G4Derm Plus, designed to complement MiMedx’s portfolio of leading surgical and wound products.

CEO Brent Ness noted a broad global market, with approximately 266 million people affected by chronic low back pain.

The move comes after SRx Health announced in December that it would be acquiring EMJ Capital, alongside a pivot to an active “Gen2” digital asset treasury strategy under activist investor Eric Jackson.

Earnings remain in focus, with Alphabet due to report on Wednesday and Amazon expected on Thursday.

ENPH lagged SEDG all of last year, but analysts are seeing brighter prospects for Enphase due to its storage battery edge.

The reverse split is intended to bring the company back into compliance with Nasdaq’s $1 minimum bid price rule.

Massimo stated that, as per the non-binding LOI, it will acquire 100% of the equity interests of FST, a company that specializes in intelligent hardware and AI-driven system-level solutions.

The company is focused on completing enrollment in its Phase 3 IFx-2.0 study with Keytruda for advanced Merkel cell carcinoma.

Shares of Strategy and Bitmine Immersion Technologies fell in pre-market trade as on-paper losses surged following the weekend crypto crash.

Elong Power captured retail traders’ attention after staging a stellar rally on Friday, even as it announced a fresh share and warrant offering.

MSTR and BMNR stocks were among the top trending tickers on Stocktwits following Bitcoin’s weekend crash.

Among the catalysts for the day are S&P flash U.S. manufacturing PMI, ISM manufacturing, and auto sales.

Kazia stated that across multiple preclinical models and patient-derived samples, NDL2 demonstrated reversal of immune exhaustion, suppression of metastatic biology, and enhanced anti-tumor activity.

Strive Asset Management CEO Matt Cole said Bitcoin looks undervalued relative to gold based on technical indicators.

CN Energy stated in its announcement that it has agreed to acquire approximately 82% of Blessing’s equity interests.

CEO Matt Cole said Strive acquired an additional 333.9 Bitcoin, lifting it into the top 10 corporate holders.

Meta Platforms forecast 2026 capital expenditures between $115 billion and $135 billion for 2026.

A responsible-gambling push in Ontario and aggressive 2026 growth plans keep momentum roaring.

REGENXBIO stated that the FDA has placed a clinical hold on the company’s experimental gene therapy program for the treatment of rare childhood diseases.

Building on the gains from last year, Wall Street is bullish on Energy Fuels and its run for 2026.

Crypto mining stocks lagged within crypto-linked equities, with MARA Holdings and Riot Platforms posting modest declines in after-hours trade.

A long-awaited missile defense contract sparks RDW’s best day in over a year and supercharges retail enthusiasm.

After a moonshot rally fueled by space hype, FJET stock cools sharply as retail sentiment flips and reality sets in.

Trump’s USA Rare Earth move ignites speculation across critical minerals.

Reports of a $1.6B government-backed investment, Greenland geopolitics, and project momentum supercharge USAR’s rally, and retail is piling in.

New Era Energy is looking to raise up to $350 million through the sale of securities that may include common stock, preferred stock, debt securities, warrants, units, and rights.

The customer behind the agreement is an AI-driven battery technology company that will use the GPU cluster to support its R&D work.

Markets digested recent gains, elevated retail activity, and focused on Trump’s trade and geopolitical developments.

60 Degrees has partnered with Runway Health to offer international travelers access to Arakoda via Runway Health’s travel medicine platform.

Corvus increased its public stock offering to $175 million from $150 million, making 7.9 million shares of its common stock available for purchase at Wednesday’s closing price of $22.15.

AREB is seeing a resurgence in investor interest, helping the stock bounce back from a disappointing 2025.

Market focus shifted toward tariff-related developments alongside upcoming U.S. economic data releases.